Evidence map›Paper›PMID 41383612›Full record

ArticleFrontiers in immunology2025

Characterization of Ty21a immunostimulatory effects in the mouse bladder.

Lenka Polak, Rim Hojeij, Valerie Cesson, Jacques-Antoine Haefliger, Thierry Roger, Ilaria Lucca, Laurent Derré, Denise Nardelli-Haefliger, Sonia Domingos-Pereira

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lenka Polak *Urology Research Unit, Department of Urology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Rim Hojeij *Urology Research Unit, Department of Urology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Valerie CessonUrology Research Unit, Department of Urology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Jacques-Antoine HaefligerDepartment of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Thierry RogerInfectious Diseases Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, Epalinges, Switzerland.
Ilaria LuccaUrology Research Unit, Department of Urology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Laurent DerréUrology Research Unit, Department of Urology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Denise Nardelli-HaefligerUrology Research Unit, Department of Urology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Sonia Domingos-PereiraUrology Research Unit, Department of Urology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intravesical treatment with

Indexed as

Salmonella entericaUrinary BladderUrinary Bladder NeoplasmsAdministration, IntravesicalAnimalsCD8-Positive T-LymphocytesCell Line, TumorFemaleMiceMice, Inbred C57BLMice, Knockoutbladder cancerchemokineintravesical immunotherapyT-cell infiltrationTLRTy21a salmonella formulationvessel permeability

Identifiers

PMID41383612
PMCPMC12689529

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.